The Russian single-component drug from Coronavirus Satellite Light showed the effectiveness of more than 80 percent among the elderly in Argentina. This is reported by the Russian Foundation for direct investment (RFI).
According to the study, published in EclinicalMedicine magazine, the drug, which is the first component of the Vaccine “Satellite V”, demonstrated efficiency from 78.6 to 83.7 percent among citizens aged 60 to 79 years.
RDIA declares that Satellite Light is effective and against hospitalization. The data of 40 thousand people received by the Ministry of Health of the province of Buenos Aires show that the grafted Russian single-component vaccine in more than 80 percent of cases avoid hospitalization.
/Media reports.